These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24585108)

  • 1. Novel molecular angiotensin converting enzyme and angiotensin receptor imaging techniques.
    Shirani J; Dilsizian V
    Curr Cardiol Rep; 2014 Apr; 16(4):466. PubMed ID: 24585108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the clinical effects of angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers: a critical review of the evidence.
    Dézsi CA
    Am J Cardiovasc Drugs; 2014 Jun; 14(3):167-73. PubMed ID: 24385234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal renin-angiotensin system blockade-wishful thinking?
    Makani H; Bangalore S; Messerli FH
    Nat Rev Cardiol; 2013 Aug; 10(8):486. PubMed ID: 23817190
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply: Optimal renin-angiotensin-aldosterone system blockade--wish fulfilled.
    Nussberger J; Bohlender J
    Nat Rev Cardiol; 2013 Aug; 10(8):486. PubMed ID: 23817186
    [No Abstract]   [Full Text] [Related]  

  • 7. Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor: similarities and differences.
    Stergiou GS; Skeva II
    Curr Top Med Chem; 2004; 4(4):473-81. PubMed ID: 14965313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together?
    Verdecchia P; Angeli F; Mazzotta G; Ambrosio G; Reboldi G
    Curr Vasc Pharmacol; 2010 Nov; 8(6):742-6. PubMed ID: 20626343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin receptor blockers: evidence for preserving target organs.
    Carson P; Giles T; Higginbotham M; Hollenberg N; Kannel W; Siragy HM
    Clin Cardiol; 2001 Mar; 24(3):183-90. PubMed ID: 11288962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.
    Arendse LB; Danser AHJ; Poglitsch M; Touyz RM; Burnett JC; Llorens-Cortes C; Ehlers MR; Sturrock ED
    Pharmacol Rev; 2019 Oct; 71(4):539-570. PubMed ID: 31537750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.
    Nussberger J; Bohlender J
    Nat Rev Cardiol; 2013 Apr; 10(4):183-4. PubMed ID: 23478259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
    Messerli FH; Bangalore S; Bavishi C; Rimoldi SF
    J Am Coll Cardiol; 2018 Apr; 71(13):1474-1482. PubMed ID: 29598869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A; Battegay E
    Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
    Pichler M; Klein W; Huber K; Pachinger O
    Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.